Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas

T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of hematology Vol. 107; no. 4; pp. 413 - 419
Main Authors Chan, Jason Yongsheng, Lim, Soon Thye
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.04.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.
AbstractList T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.
T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.
T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the West. Through the efforts of international collaboration, significant progress has been made especially on the biological understanding and clinical management of rare lymphoma subtypes including NK/T-cell lymphomas and monomorphic epitheliotropic intestinal T-cell lymphoma. In this review, we summarize the current status of lymphoma research conducted by the Asian Lymphoma Study Group and highlight key updates on the advancement of T and NK-cell lymphoma research.
Author Chan, Jason Yongsheng
Lim, Soon Thye
Author_xml – sequence: 1
  givenname: Jason Yongsheng
  surname: Chan
  fullname: Chan, Jason Yongsheng
  organization: Division of Medical Oncology, National Cancer Centre Singapore, Cancer Science Institute of Singapore, National University of Singapore, SingHealth Duke-NUS Blood Cancer Centre
– sequence: 2
  givenname: Soon Thye
  surname: Lim
  fullname: Lim, Soon Thye
  email: lim.soon.thye@singhealth.com.sg
  organization: Division of Medical Oncology, National Cancer Centre Singapore, Office of Education, Duke-NUS Medical School, SingHealth Duke-NUS Blood Cancer Centre
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29380182$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1OGzEUha0KVAL0AbpBlrrpxsX2ePzTHYpaqIjCgnRtefwDg2bsYM8g5e07IWlVRYLV3Xyf77k-p-AopugB-EzwN4KxuCyEElkjTCSiDHPEP4AZkbxGlRDsCMywojWqBcEn4LSUJ4yJwEx8BCdUVXKy6AyslunFdzC00bXxocCQUw-HRw-vSmsiXGz69WPqDbwfRreB1zmN6-8wJDsWmCJcQRMdXN4i67sOdnu4nIPjYLriP-3nGfj988dqfoMWd9e_5lcLZFmlBkQFc17YhkuvHPe1JcTVIRhBWENl1WBGp0Nsw1jgjZJMCkW5C0Y6RhizojoDX3fvrnN6Hn0ZdN-WbRQTfRqLJkpVGHMl-IR-OUCf0pjjlO6VqgWthZyoiz01Nr13ep3b3uSN_vtfE0B2gM2plOzDP4Rgve1E7zrRE623nejtanHg2HYwQ5vikE3bvWvSnVmmLfHB5_9Cvyn9AdYEnWE
CitedBy_id crossref_primary_10_1038_s41467_019_12032_9
crossref_primary_10_1038_s41598_019_51522_0
crossref_primary_10_1007_s12149_021_01598_4
crossref_primary_10_3390_life11080838
crossref_primary_10_5045_br_2021_2020328
crossref_primary_10_1182_bloodadvances_2020001782
crossref_primary_10_3389_fimmu_2023_1068662
crossref_primary_10_3389_fonc_2022_796738
Cites_doi 10.1200/JCO.2009.23.8592
10.1182/blood-2012-05-431460
10.3109/0284186X.2010.516272
10.1016/S1470-2045(13)70450-9
10.1016/S1470-2045(09)70265-7
10.1038/leu.2013.41
10.1016/S1470-2045(15)00533-1
10.1200/JCO.2012.45.6541
10.1038/bmt.2014.65
10.1182/blood-2016-12-756841
10.1158/1078-0432.CCR-12-1064
10.1186/1756-8722-6-86
10.1186/s13045-017-0452-9
10.3109/10428194.2011.569038
10.1155/2011/790871
10.1038/ng.3358
10.1038/leu.2016.13
10.1200/JCO.2009.23.8295
10.1182/blood-2013-11-536359
10.1007/s10637-012-9889-4
10.1200/JCO.2005.04.1384
10.1016/S1470-2045(16)30148-6
10.3960/jslrt.17018
10.1056/NEJMc1605684
10.1097/PAS.0b013e318222dfcd
10.18632/oncotarget.3776
10.1016/j.bbmt.2015.05.003
10.1038/leu.2015.44
10.7150/ijbs.7.1122
10.1002/ajh.23213
10.1038/leu.2010.295
10.1007/s10637-015-0258-y
10.1097/PAS.0000000000000312
10.1200/JCO.2011.35.6287
10.5045/br.2015.50.4.254
10.1182/blood-2008-10-185256
10.1200/JCO.2011.40.7098
10.1016/S2352-3026(15)00002-2
10.1158/2159-8290.CD-12-0028
10.1093/annonc/mdx684
10.1182/blood.V128.22.4128.4128
10.1200/JCO.2017.35.15_suppl.7549
10.3324/haematol.2017.180430
ContentType Journal Article
Copyright The Japanese Society of Hematology 2018
International Journal of Hematology is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: The Japanese Society of Hematology 2018
– notice: International Journal of Hematology is a copyright of Springer, (2018). All Rights Reserved.
DBID AAYXX
CITATION
NPM
3V.
7RV
7T5
7T7
7TM
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s12185-018-2406-6
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Medical Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Technology Research Database
ProQuest One Academic Middle East (New)
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1865-3774
EndPage 419
ExternalDocumentID 29380182
10_1007_s12185_018_2406_6
Genre Journal Article
Review
GroupedDBID ---
--K
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
1B1
1N0
203
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG5
HG6
HLICF
HMCUK
HMJXF
HRMNR
HZ~
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LLZTM
M1P
M41
M4Y
MA-
N9A
NAPCQ
NPVJJ
NQ-
NQJWS
NU0
O9-
O93
O9I
O9J
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RIG
ROL
RPX
RPZ
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WJK
WK8
WOW
X7M
YLTOR
Z45
Z7U
Z81
Z82
Z87
ZMTXR
ZOVNA
ZXP
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
NPM
PJZUB
PPXIY
7T5
7T7
7TM
7XB
8FD
8FK
C1K
FR3
H94
K9.
P64
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c439t-274de7cb68e9d6e5c11d5ffa714b283b042377cb44f6b98487926dfa8d4144c73
IEDL.DBID 7X7
ISSN 0925-5710
1865-3774
IngestDate Fri Jul 11 07:02:39 EDT 2025
Sat Jul 26 02:18:05 EDT 2025
Mon Jul 21 06:06:01 EDT 2025
Tue Jul 01 03:47:55 EDT 2025
Thu Apr 24 23:12:17 EDT 2025
Fri Feb 21 02:31:24 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Enteropathy-associated T-cell lymphoma
NK/T-cell lymphoma
JAK-STAT pathway
Epstein–Barr virus
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-274de7cb68e9d6e5c11d5ffa714b283b042377cb44f6b98487926dfa8d4144c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
OpenAccessLink https://link.springer.com/content/pdf/10.1007%2Fs12185-018-2406-6.pdf
PMID 29380182
PQID 1993572578
PQPubID 55446
PageCount 7
ParticipantIDs proquest_miscellaneous_1993006976
proquest_journals_1993572578
pubmed_primary_29380182
crossref_primary_10_1007_s12185_018_2406_6
crossref_citationtrail_10_1007_s12185_018_2406_6
springer_journals_10_1007_s12185_018_2406_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180400
2018-4-00
2018-Apr
20180401
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 4
  year: 2018
  text: 20180400
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle International journal of hematology
PublicationTitleAbbrev Int J Hematol
PublicationTitleAlternate Int J Hematol
PublicationYear 2018
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Kwong, Anderson, Advani, Kim, Levine, Lim (CR1) 2009; 10
Chan (CR22) 2011; 7
Yang, Zhang, Zhu, Cao, Yuan, Xu, Wu, Wang, Wu, Lu, Zhu, Qian, Zhang, Hou, Liu, Li (CR27) 2015; 29
Venkatakrishnan, Kim, Lin, Thye, Chng, Ma, Chen, Zhou, Liu, Kelly, Kim (CR23) 2015; 33
Ito, Kimura, Maeda, Hashimoto, Ishida, Izutsu, Fukushima, Isobe, Takizawa, Hasegawa, Kobayashi, Okamura, Kobayashi, Yamaguchi, Suzumiya, Hyo, Nakamura, Kawa, Oshimi, Suzuki (CR29) 2012; 18
Jiang, Gu, Yan, Zhao, Xie, Zhang, Pan, Hu, Cai, Dong, Huang, Wang, Shen, Meng, Zhou, Hu, Wang, Liu, Yang, Zhang, Wang, Wang, Peng, Chen, Sun, Ding, Shi, Hou, Yan, Shi, Xu, Li, Lu, Zheng, Xue, Zhao, Chen, Chen (CR33) 2015; 47
Kim, Yoon, Jaccard, Chng, Lim, Hong, Park, Chang, Maeda, Ishida, Shin, Kim, Jeong, Yang, Jo, Lee, Choi, Lee, Chen, Kim, Jung, Murayama, Oki, Advani, d’Amore, Schmitz, Suh, Suzuki, Kwong, Lin, Kim (CR28) 2016; 17
Tan, Chuang, Tang, Tan, Ko, Chuah, Ng, Chng, Gatter, Loong, Liu, Hosking, Cheah, Teh, Tay, Koh, Lim (CR40) 2013; 27
Li, Xia, Feng, Chen, Li, Cui, Cai, Sim, Nairismägi, Laurensia, Meah, Liu, Guo, Chen, Feng, Pang, Chen, Chew, Ebstein, Foo, Liu, Ha, Khoo, Chin, Zeng, Aung, Chowbay, Diong, Zhang, Liu, Tang, Tao, Quek, Mohamad, Tan, Teh, Ng, Chng, Ong, Okada, Raychaudhuri, Lim, Tan, Peng, Khor, Bei (CR32) 2016; 17
Suzuki, Kwong, Maeda, Sakai, Kim, Suh, Ishida, Izutsu, Isobe, Maeda, Sueoka, Okoshi, Takizawa, Kobayashi, Nakamura, Suzumiya, Oshimi, Yamaguchi (CR14) 2015; 33
Au, Weisenburger, Intragumtornchai, Nakamura, Kim, Sng, Vose, Armitage, Liang (CR3) 2009; 113
Tse, Kwong (CR7) 2017; 10
Kwong, Chan, Tan, Kim, Poon, Mow, Khong, Loong, Au-Yeung, Iqbal, Phipps, Tse (CR19) 2017; 129
Kim, Moon, Moon, Park, Byeon, Kim (CR24) 2015; 50
Ahn, Kim, Hwang, Ko, Tang, Lim, Kim (CR21) 2013; 31
Iqbal, Wright, Wang, Rosenwald, Gascoyne, Weisenburger, Greiner, Smith, Guo, Wilcox, Teh, Lim, Tan, Rimsza, Jaffe, Campo, Martinez, Delabie, Braziel, Cook, Tubbs, Ott, Geissinger, Gaulard, Piccaluga, Pileri, Au, Nakamura, Seto, Berger, de Leval, Connors, Armitage, Vose, Chan, Staudt (CR42) 2014; 123
Kwong, Kim, Lim, Kim, Tang, Tse, Leung, Chim (CR12) 2012; 120
Hwang, Koh, Lim, Linn, Loh, Koh, Diong, Lee, Zhang, Rajgor, Gandhi, Shah, Goh (CR16) 2011; 52
Lee, Suh, Park, Ko, Bang, Lee, Lee, Huh, Oh, Kwon, Kim, Lee, Kim, Park, Oh, Kim, Jung, Park, Kim (CR26) 2006; 24
Kim, Choi, Hyun, Ki, Oh, Ahn, Ko, Choi, Jung, Khong, Tang, Yan, Lim, Kwong, Kim (CR30) 2015; 2
Lee, Park, Kang, Kim, Hwang, Lee, Kwak, Park, Yoo, Kim, Kim, Ko (CR35) 2015; 6
Chan, Chan, Cheuk, Wan, Lee, Lui, Chan (CR38) 2011; 35
Nairismägi, Pang, Huang, Tan, Lim, Li, Ha, Laurensia, Wijaya, Ng, Santoso, Teh, Tan, Lim, Ong (CR44) 2016; 128
Tan, Ooi, Ang, Koh, Wong, Dykema, Ngeow, Loong, Gatter, Tan, Lim, Furge, Tao, Lim, Loong, Cheah, Teh (CR39) 2011; 25
Tan, Tan, Lim, Kim, Kim, Advani, Kwong (CR2) 2013; 14
Takata, Hong, Sitthinamsuwan, Loong, Tan, Liau, Hsieh, Ng, Yang, Pongpruttipan, Sukpanichnant, Kwong, Hyeh Ko, Cho, Chng, Matsushita, Yoshino, Chuang (CR5) 2015; 39
Hari, Raj, Olteanu (CR25) 2016; 375
Koo, Tan, Tang, Poon, Allen, Tan, Chong, Ong, Tay, Tao, Quek, Loong, Yeoh, Yap, Lee, Lim, Tan, Goh, Cutcutache, Yu, Ng, Rajasegaran, Heng, Gan, Ong, Rozen, Tan, Teh, Lim (CR34) 2012; 2
Lim, Song, Lim, Laurensia, Pang, Nagarajan, Wijaya, Tan, Tang, Nairismägi, Ong (CR36) 2017; 35
Yamaguchi, Tobinai, Oguchi, Ishizuka, Kobayashi, Isobe, Ishizawa, Maseki, Itoh, Usui, Wasada, Kinoshita, Ohshima, Matsuno, Terauchi, Nawano, Ishikura, Kagami, Hotta, Oshimi (CR8) 2009; 27
Ng, Chung, Kato, Nakamura, Takahashi, Ko, Khoury, Yin, Soong, Jeyasekharan, Hoppe, Selvarajan, Tan, Lim, Ong, Nairismägi, Maheshwari, Choo, Fan, Lee, Chuang, Chng (CR43) 2017
Kim, Jung, Chuang, Hong, Guo, Cao, Hong, Suzuki, Kang, Won, Chng, Kwong, Suh, Song, Zhu, Tay, Lim, Suzumiya, Lin, Kim (CR4) 2013; 16
Farid, Yau, Tay, Quek, Tao, Koo, Loong, Lim (CR20) 2011; 50
Yhim, Kim, Mun, Moon, Chae, Park, Jo, Kim, Yoon, Cheong, Kwak, Lee, Kim, Suh, Yang (CR18) 2015; 21
Tse, Chan, Koh, Chng, Kim, Tang, Lim, Lie, Kwong (CR17) 2014; 49
Tse, Gill, Loong, Kim, Ng, Tang, Ko, Chng, Lim, Kim, Kwong (CR37) 2012; 87
Kwong, Kim, Tse, Oh, Kwak, Eom, Do, Mun, Lee, Shin, Suh, Chuang, Lee, Lim, Izutsu, Suzuki, Relander, d’Amore, Schmitz, Jaccard, Kim (CR13) 2017
Kim, Kim, Kim, Kim, Suh, Huh, Lee, Kim, Cho, Lee, Kang, Eom, Pyo, Ahn, Ko, Kim (CR10) 2009; 27
Schmitt, Sako, Bagot, Huang, Gaulard, Bensussan (CR31) 2011; 2011
Yamaguchi, Miyazaki (CR6) 2017; 57
Yamaguchi, Tobinai, Oguchi, Ishizuka, Kobayashi, Isobe, Ishizawa, Maseki, Itoh, Usui, Wasada, Kinoshita, Hotta, Tsukasaki, Oshimi (CR9) 2012; 30
Chan, Tang, Ng, Shih, Tay, Tao, Quek, Lim (CR15) 2012; 30
Yamaguchi, Kwong, Kim, Maeda, Hashimoto, Suh, Izutsu, Ishida, Isobe, Sueoka, Suzumiya, Kodama, Kimura, Hyo, Nakamura, Oshimi, Suzuki (CR11) 2011; 29
Nairismägi, Tan, Lim, Nagarajan, Ng, Rajasegaran, Huang, Lim, Laurensia, Wijaya, Li, Cutcutache, Pang, Thangaraju, Ha, Khoo, Chin, Dey, Poore, Tan, Koh, Sabai, Rao, Chuah, Ho, Ng, Chuang, Zhang, Liu, Pongpruttipan, Ko, Cheah, Karim, Chng, Tang, Tao, Tay, Farid, Quek, Rozen, Tan, Teh, Lim, Tan, Ong (CR41) 2016; 30
M Yamaguchi (2406_CR6) 2017; 57
E Tse (2406_CR17) 2014; 49
S Lee (2406_CR35) 2015; 6
K Takata (2406_CR5) 2015; 39
ML Nairismägi (2406_CR41) 2016; 30
L Jiang (2406_CR33) 2015; 47
SY Tan (2406_CR39) 2011; 25
M Yamaguchi (2406_CR9) 2012; 30
ML Nairismägi (2406_CR44) 2016; 128
GC Koo (2406_CR34) 2012; 2
YL Kwong (2406_CR12) 2012; 120
HK Kim (2406_CR24) 2015; 50
A Chan (2406_CR15) 2012; 30
WY Au (2406_CR3) 2009; 113
C Schmitt (2406_CR31) 2011; 2011
SJ Kim (2406_CR10) 2009; 27
K Venkatakrishnan (2406_CR23) 2015; 33
E Tse (2406_CR7) 2017; 10
M Yamaguchi (2406_CR11) 2011; 29
JY Chan (2406_CR22) 2011; 7
SJ Kim (2406_CR28) 2016; 17
P Hari (2406_CR25) 2016; 375
R Suzuki (2406_CR14) 2015; 33
JK Chan (2406_CR38) 2011; 35
M Farid (2406_CR20) 2011; 50
Y Ito (2406_CR29) 2012; 18
SB Ng (2406_CR43) 2017
J Lee (2406_CR26) 2006; 24
Y Yang (2406_CR27) 2015; 29
Z Li (2406_CR32) 2016; 17
SJ Kim (2406_CR30) 2015; 2
ST Lim (2406_CR36) 2017; 35
YL Kwong (2406_CR1) 2009; 10
D Tan (2406_CR2) 2013; 14
SY Tan (2406_CR40) 2013; 27
SJ Kim (2406_CR4) 2013; 16
WY Hwang (2406_CR16) 2011; 52
E Tse (2406_CR37) 2012; 87
YL Kwong (2406_CR19) 2017; 129
HK Ahn (2406_CR21) 2013; 31
HY Yhim (2406_CR18) 2015; 21
J Iqbal (2406_CR42) 2014; 123
M Yamaguchi (2406_CR8) 2009; 27
YL Kwong (2406_CR13) 2017
References_xml – volume: 27
  start-page: 6027
  issue: 35
  year: 2009
  end-page: 6032
  ident: CR10
  article-title: Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.23.8592
– volume: 120
  start-page: 2973
  issue: 15
  year: 2012
  end-page: 2980
  ident: CR12
  article-title: SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
  publication-title: Blood
  doi: 10.1182/blood-2012-05-431460
– volume: 50
  start-page: 589
  issue: 4
  year: 2011
  end-page: 590
  ident: CR20
  article-title: A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2010.516272
– volume: 14
  start-page: e548
  issue: 12
  year: 2013
  end-page: e561
  ident: CR2
  article-title: Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70450-9
– volume: 10
  start-page: 1093
  issue: 11
  year: 2009
  end-page: 1101
  ident: CR1
  article-title: Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(09)70265-7
– volume: 27
  start-page: 1688
  issue: 8
  year: 2013
  end-page: 1696
  ident: CR40
  article-title: Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype
  publication-title: Leukemia
  doi: 10.1038/leu.2013.41
– volume: 33
  start-page: 140
  issue: S1
  year: 2015
  ident: CR14
  article-title: 5-year follow-up of the SMILE phase II study for newly-diagnosed stage IV, relapsed or refractory extranodal NK/T-cell lymphoma, nasal type
  publication-title: Hematol Oncol
– volume: 17
  start-page: 389
  issue: 3
  year: 2016
  end-page: 400
  ident: CR28
  article-title: A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00533-1
– volume: 30
  start-page: 4044
  issue: 32
  year: 2012
  end-page: 4046
  ident: CR9
  article-title: Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.45.6541
– volume: 49
  start-page: 902
  issue: 7
  year: 2014
  end-page: 906
  ident: CR17
  article-title: Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2014.65
– volume: 129
  start-page: 2437
  issue: 17
  year: 2017
  end-page: 2442
  ident: CR19
  article-title: PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing -asparaginase
  publication-title: Blood
  doi: 10.1182/blood-2016-12-756841
– volume: 18
  start-page: 4183
  issue: 15
  year: 2012
  end-page: 4190
  ident: CR29
  article-title: Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-1064
– volume: 16
  start-page: 86
  issue: 6
  year: 2013
  ident: CR4
  article-title: Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-6-86
– volume: 10
  start-page: 85
  issue: 1
  year: 2017
  ident: CR7
  article-title: The diagnosis and management of NK/T-cell lymphomas
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-017-0452-9
– year: 2017
  ident: CR13
  article-title: Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
  publication-title: Ann Oncol
– year: 2017
  ident: CR43
  article-title: EBV-associated primary nodal T/NK-cell lymphoma shows distinct molecular signature and copy number changes
  publication-title: Haematologica
– volume: 52
  start-page: 1382
  issue: 7
  year: 2011
  end-page: 1386
  ident: CR16
  article-title: Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428194.2011.569038
– volume: 2011
  start-page: 790871
  year: 2011
  ident: CR31
  article-title: Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets
  publication-title: J Biomed Biotechnol
  doi: 10.1155/2011/790871
– volume: 47
  start-page: 1061
  issue: 9
  year: 2015
  end-page: 1066
  ident: CR33
  article-title: Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
  publication-title: Nat Genet
  doi: 10.1038/ng.3358
– volume: 30
  start-page: 1311
  issue: 6
  year: 2016
  end-page: 1319
  ident: CR41
  article-title: JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
  publication-title: Leukemia
  doi: 10.1038/leu.2016.13
– volume: 35
  start-page: 7549
  issue: 15 suppl
  year: 2017
  ident: CR36
  article-title: Oncogenic activation of STAT3 pathway drives PD-L1 expression in natural killer/T cell lymphoma
  publication-title: J Clin Oncol
– volume: 27
  start-page: 5594
  issue: 33
  year: 2009
  end-page: 5600
  ident: CR8
  article-title: Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.23.8295
– volume: 123
  start-page: 2915
  issue: 19
  year: 2014
  end-page: 2923
  ident: CR42
  article-title: Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2013-11-536359
– volume: 31
  start-page: 469
  issue: 2
  year: 2013
  end-page: 472
  ident: CR21
  article-title: Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
  publication-title: Investig New Drugs
  doi: 10.1007/s10637-012-9889-4
– volume: 24
  start-page: 612
  issue: 4
  year: 2006
  end-page: 618
  ident: CR26
  article-title: Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.1384
– volume: 17
  start-page: 1240
  issue: 9
  year: 2016
  end-page: 1247
  ident: CR32
  article-title: Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(16)30148-6
– volume: 57
  start-page: 98
  year: 2017
  end-page: 108
  ident: CR6
  article-title: Current treatment approaches for NK/T-cell lymphoma
  publication-title: J Clin Exp Hematop
  doi: 10.3960/jslrt.17018
– volume: 375
  start-page: 1501
  issue: 15
  year: 2016
  end-page: 1502
  ident: CR25
  article-title: Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1605684
– volume: 35
  start-page: 1557
  issue: 10
  year: 2011
  end-page: 1569
  ident: CR38
  article-title: Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e318222dfcd
– volume: 6
  start-page: 17764
  issue: 19
  year: 2015
  end-page: 17776
  ident: CR35
  article-title: Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3776
– volume: 21
  start-page: 1597
  issue: 9
  year: 2015
  end-page: 1604
  ident: CR18
  article-title: Consortium for improving survival of lymphoma study. Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2015.05.003
– volume: 128
  start-page: 4128
  year: 2016
  ident: CR44
  article-title: Generation of non-Hodgkin lymphoma patient-derived xenografts and in depth characterization of a monomorphic epitheliotropic intestinal T-cell lymphoma model
  publication-title: Blood
– volume: 29
  start-page: 1571
  issue: 7
  year: 2015
  end-page: 1577
  ident: CR27
  article-title: Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study
  publication-title: Leukemia
  doi: 10.1038/leu.2015.44
– volume: 7
  start-page: 1122
  issue: 8
  year: 2011
  end-page: 1144
  ident: CR22
  article-title: A clinical overview of centrosome amplification in human cancers
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.7.1122
– volume: 87
  start-page: 663
  issue: 7
  year: 2012
  end-page: 668
  ident: CR37
  article-title: Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group
  publication-title: Am J Hematol
  doi: 10.1002/ajh.23213
– volume: 25
  start-page: 555
  issue: 3
  year: 2011
  end-page: 557
  ident: CR39
  article-title: Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma
  publication-title: Leukemia
  doi: 10.1038/leu.2010.295
– volume: 33
  start-page: 942
  issue: 4
  year: 2015
  end-page: 953
  ident: CR23
  article-title: Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
  publication-title: Investig New Drugs
  doi: 10.1007/s10637-015-0258-y
– volume: 39
  start-page: 1
  issue: 1
  year: 2015
  end-page: 12
  ident: CR5
  article-title: Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000312
– volume: 29
  start-page: 4410
  issue: 33
  year: 2011
  end-page: 4416
  ident: CR11
  article-title: Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.35.6287
– volume: 50
  start-page: 254
  issue: 4
  year: 2015
  end-page: 256
  ident: CR24
  article-title: Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
  publication-title: Blood Res
  doi: 10.5045/br.2015.50.4.254
– volume: 113
  start-page: 3931
  issue: 17
  year: 2009
  end-page: 3937
  ident: CR3
  article-title: Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
  publication-title: Blood
  doi: 10.1182/blood-2008-10-185256
– volume: 30
  start-page: 1015
  issue: 9
  year: 2012
  end-page: 1016
  ident: CR15
  article-title: To SMILE or not: supportive care matters
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.40.7098
– volume: 2
  start-page: e66
  issue: 2
  year: 2015
  end-page: e74
  ident: CR30
  article-title: Risk stratification on the basis of Deauville score on PET–CT and the presence of Epstein–Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(15)00002-2
– volume: 2
  start-page: 591
  issue: 7
  year: 2012
  end-page: 597
  ident: CR34
  article-title: Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-12-0028
– volume: 17
  start-page: 389
  issue: 3
  year: 2016
  ident: 2406_CR28
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00533-1
– volume: 6
  start-page: 17764
  issue: 19
  year: 2015
  ident: 2406_CR35
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3776
– volume: 14
  start-page: e548
  issue: 12
  year: 2013
  ident: 2406_CR2
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70450-9
– volume: 375
  start-page: 1501
  issue: 15
  year: 2016
  ident: 2406_CR25
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1605684
– volume: 30
  start-page: 4044
  issue: 32
  year: 2012
  ident: 2406_CR9
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.45.6541
– year: 2017
  ident: 2406_CR13
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx684
– volume: 30
  start-page: 1015
  issue: 9
  year: 2012
  ident: 2406_CR15
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.40.7098
– volume: 128
  start-page: 4128
  year: 2016
  ident: 2406_CR44
  publication-title: Blood
  doi: 10.1182/blood.V128.22.4128.4128
– volume: 7
  start-page: 1122
  issue: 8
  year: 2011
  ident: 2406_CR22
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.7.1122
– volume: 31
  start-page: 469
  issue: 2
  year: 2013
  ident: 2406_CR21
  publication-title: Investig New Drugs
  doi: 10.1007/s10637-012-9889-4
– volume: 113
  start-page: 3931
  issue: 17
  year: 2009
  ident: 2406_CR3
  publication-title: Blood
  doi: 10.1182/blood-2008-10-185256
– volume: 123
  start-page: 2915
  issue: 19
  year: 2014
  ident: 2406_CR42
  publication-title: Blood
  doi: 10.1182/blood-2013-11-536359
– volume: 24
  start-page: 612
  issue: 4
  year: 2006
  ident: 2406_CR26
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.1384
– volume: 27
  start-page: 5594
  issue: 33
  year: 2009
  ident: 2406_CR8
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.23.8295
– volume: 129
  start-page: 2437
  issue: 17
  year: 2017
  ident: 2406_CR19
  publication-title: Blood
  doi: 10.1182/blood-2016-12-756841
– volume: 87
  start-page: 663
  issue: 7
  year: 2012
  ident: 2406_CR37
  publication-title: Am J Hematol
  doi: 10.1002/ajh.23213
– volume: 29
  start-page: 4410
  issue: 33
  year: 2011
  ident: 2406_CR11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.35.6287
– volume: 52
  start-page: 1382
  issue: 7
  year: 2011
  ident: 2406_CR16
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428194.2011.569038
– volume: 33
  start-page: 942
  issue: 4
  year: 2015
  ident: 2406_CR23
  publication-title: Investig New Drugs
  doi: 10.1007/s10637-015-0258-y
– volume: 35
  start-page: 7549
  issue: 15 suppl
  year: 2017
  ident: 2406_CR36
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.35.15_suppl.7549
– volume: 16
  start-page: 86
  issue: 6
  year: 2013
  ident: 2406_CR4
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-6-86
– volume: 33
  start-page: 140
  issue: S1
  year: 2015
  ident: 2406_CR14
  publication-title: Hematol Oncol
– volume: 10
  start-page: 1093
  issue: 11
  year: 2009
  ident: 2406_CR1
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(09)70265-7
– volume: 27
  start-page: 6027
  issue: 35
  year: 2009
  ident: 2406_CR10
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.23.8592
– volume: 2
  start-page: e66
  issue: 2
  year: 2015
  ident: 2406_CR30
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(15)00002-2
– volume: 39
  start-page: 1
  issue: 1
  year: 2015
  ident: 2406_CR5
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000312
– volume: 21
  start-page: 1597
  issue: 9
  year: 2015
  ident: 2406_CR18
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2015.05.003
– volume: 29
  start-page: 1571
  issue: 7
  year: 2015
  ident: 2406_CR27
  publication-title: Leukemia
  doi: 10.1038/leu.2015.44
– volume: 30
  start-page: 1311
  issue: 6
  year: 2016
  ident: 2406_CR41
  publication-title: Leukemia
  doi: 10.1038/leu.2016.13
– volume: 47
  start-page: 1061
  issue: 9
  year: 2015
  ident: 2406_CR33
  publication-title: Nat Genet
  doi: 10.1038/ng.3358
– volume: 120
  start-page: 2973
  issue: 15
  year: 2012
  ident: 2406_CR12
  publication-title: Blood
  doi: 10.1182/blood-2012-05-431460
– volume: 35
  start-page: 1557
  issue: 10
  year: 2011
  ident: 2406_CR38
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e318222dfcd
– year: 2017
  ident: 2406_CR43
  publication-title: Haematologica
  doi: 10.3324/haematol.2017.180430
– volume: 27
  start-page: 1688
  issue: 8
  year: 2013
  ident: 2406_CR40
  publication-title: Leukemia
  doi: 10.1038/leu.2013.41
– volume: 18
  start-page: 4183
  issue: 15
  year: 2012
  ident: 2406_CR29
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-1064
– volume: 10
  start-page: 85
  issue: 1
  year: 2017
  ident: 2406_CR7
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-017-0452-9
– volume: 2
  start-page: 591
  issue: 7
  year: 2012
  ident: 2406_CR34
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-12-0028
– volume: 25
  start-page: 555
  issue: 3
  year: 2011
  ident: 2406_CR39
  publication-title: Leukemia
  doi: 10.1038/leu.2010.295
– volume: 50
  start-page: 254
  issue: 4
  year: 2015
  ident: 2406_CR24
  publication-title: Blood Res
  doi: 10.5045/br.2015.50.4.254
– volume: 17
  start-page: 1240
  issue: 9
  year: 2016
  ident: 2406_CR32
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(16)30148-6
– volume: 49
  start-page: 902
  issue: 7
  year: 2014
  ident: 2406_CR17
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2014.65
– volume: 2011
  start-page: 790871
  year: 2011
  ident: 2406_CR31
  publication-title: J Biomed Biotechnol
  doi: 10.1155/2011/790871
– volume: 57
  start-page: 98
  year: 2017
  ident: 2406_CR6
  publication-title: J Clin Exp Hematop
  doi: 10.3960/jslrt.17018
– volume: 50
  start-page: 589
  issue: 4
  year: 2011
  ident: 2406_CR20
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2010.516272
SSID ssj0017047
Score 2.2252245
SecondaryResourceType review_article
Snippet T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the...
T and NK-cell lymphomas are aggressive neoplasms with a unique epidemiological distribution, demonstrating higher prevalence in Asian countries compared to the...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 413
SubjectTerms Epidemiology
Hematology
International cooperation
Intestine
Lymphocytes T
Lymphoma
Medicine
Medicine & Public Health
Neoplasms
Oncology
Progress in Hematology
T-cell lymphoma
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA5aQbyIb6tVInhSAt1HsrveiliK2p5a6G3ZPNZL3RW3Ffrvnck-qlQFz5lkl5kk802-mYSQa8kBh6bIqYfcZ-DxDJOAS5nWKhDG84LQMrrDkRhM_Mcpn1Z13EWd7V5TknanXhW7gTfCRLMQGQHBxCbZ4hi6wySeuL2GOgi69lWxbuRyxsF_1lTmT0N8d0ZrCHONHbVOp79Hdiu0SHuleffJhskOyPaw4sMPyXiUf5gZtcRz9lJQLBahAOloD2sj6fMSbJW_JhSzBZfUnjPd0TRXi4LmGR3TJNN09MTw9J7OKuHiiEz6D-P7AaveSWAKlDtnEFhqEygpQhNpYbhyHM3TNAkcXwJ6kDb1Bdp9PxUyCiFEiVyh0yTUPoRTKvCOSSvLM3NKqAMBih8ZFUrASSqJpDYa1qX2kNDkvmiTbq2wWFWXiONbFrN4df0x6jgGHceo4xi63DRd3sobNP4S7tRWiKvFVMSYY8gD3Fva5KpphmWA2kkyky9KGbx1OYAhTkrrNV8DRAN-OHTb5LY255fBf_uVs39Jn5MdF-eVzenpkNb8fWEuAK7M5aWdnp8Bo9yA
  priority: 102
  providerName: Springer Nature
Title Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas
URI https://link.springer.com/article/10.1007/s12185-018-2406-6
https://www.ncbi.nlm.nih.gov/pubmed/29380182
https://www.proquest.com/docview/1993572578
https://www.proquest.com/docview/1993006976
Volume 107
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdrAqUvZR9tl60rGvRpQyx2LMnuy_BGsrA0YYwEsidjfXgvqd3WySD_fe8UOdkIy5PBlmVzJ-l-p9_pjpBrxQGHFsipxzxiYPEsU4BLmTFaCtvrydgxuuOJGM6i73M-9xtutQ-rbNZEt1CbSuMe-ScMNOMSB9jn-weGVaOQXfUlNI5IG1OXYUiXnG8drkB2XYGxbhJyxsGUNqymOzoHtg3D1mLkFwQT_9qlPbC5R5Q6-zN4Tk49cKTpRtMvyDNbviTHY0-NvyLTSfXHLqjjoMvfNcVzIxTQHU3xmCS9XYPaqrucYuDgmrotpxtaVHpV06qkU5qXhk5GDDfy6cI3rs_IbNCffh0yXzKBaZDzkoGPaazUSsQ2McJyHQSGF0Uug0gBkFAuCgaeR1EhVBKDt5KEwhR5bCLwrLTsnZNWWZX2NaEB-CpRYnWsADLpPFHGGpiipofcJo9Eh3QbgWXa5xPHshaLbJcJGWWcgYwzlHEGr3zYvnK_SaZxqPFlo4XMz6s6242CDnm_fQwzAqWTl7ZabdpgAmYJXVxstLf9GoAbMMlx2CEfG3X-1fn_fuXN4V95S05CHEgunueStJaPK_sOoMpSXbnxeEXa6bdfoz5cv_QnP37C3VmYPgHN5-Qw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeJr7pNsBI8AKyaBPbSZAQGrCpo22EUCftLYs_spcuGaQd6j_F38idk3Sgib3t2Y5j3Z19v_Pv7AN4pSXi0II49VgKjh7PcY24lFtrIuXCMIo9oztN1ehIfD2Wxxvwu7sLQ2mV3Z7oN2pbGTojf0eJZjIiA_t4_oNT1ShiV7sSGo1ZjN3qF4Zs9YfDL6jf10FwsD_7POJtVQFucCoLjmGYdZHRKnaJVU6a4dDKosijodDoa7VPFMF2IQqlkxgBfRIoW-SxFRh8mCjEcW_BpggxlOnB5qf99Nv3NW8RDXxJs0ESSC7ReXc8qr-sh96UEuViYjQUV_96wivw9go16z3ewT3YaqEq22ts6z5suPIB3J62ZPxDmKXVhZszz3qXpzWjmyoM8STbo4uZbLJCQ6nOckapiivmD7nes6Iyy5pVJZuxvLQsHXOiDti87Vw_gqMbEedj6JVV6Z4CG2J0JBJnYo0gzeSJts7ipmBDYlOlUH0YdALLTPuCORXSmGeXby-TjDOUcUYyzvCTN-tPzpvnO67rvNtpIWtXcp1d2l0fXq6bcQ2SdPLSVcumDz35HOEQTxrtrf-GcApBQBz04W2nzr8G_99Utq-fygu4M5pNJ9nkMB3vwN2AjMpnE-1Cb_Fz6Z4hUFro5611Mji56QXxB4JsHgk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dTxQxEJ8gJMQXI6JyCloTfNE03H603SUhhogX4ODiw5Hc27r9WF6OXXTvNPev-dc50909MATeeG6320xnOr_pb9oB2NUCcWhBnHoiYo4ez3GNuJRba5R0UaQSz-iej-TxRXw6EZMV-NvdhaG0ym5P9Bu1rQydke9RoplQpGB7RZsW8f1o8OX6J6cKUsS0duU0GhUZusUfDN_qg5MjXOuPYTj4Nv56zNsKA9zgtGYcQzLrlNEycamVTpggsKIochXEGv2u9kkj2B7HhdRpguA-DaUt8sTGGIgYFeG4T2BNRSIgG1OTZbAXqL4vbtZPQ8EFuvGOUfXX9tCvUspcQtyG5PJ_n3gH6N4hab3vGzyHZy1oZYeNlm3AiitfwPp5S8tvwnhU_XZT5vnv8rJmdGeFIbJkh3RFk50tUGWqq5xR0uKC-eOufVZUZl6zqmRjlpeWjYacSAQ2bTvXL-HiUYT5ClbLqnRbwAKMk-LUmUQjXDN5qq2zuD3YiHhVEcse9DuBZaZ9y5xKakyzm1eYScYZyjgjGWf4yaflJ9fNQx4Pdd7uViFrbbrObjSwBx-WzWiNJJ28dNW86UOPPysc4nWzesu_IbBCOJCEPfjcLeetwe-bypuHp_Ie1tEMsrOT0fAtPA1Jp3xa0Taszn7N3Q4ippl-51WTwY_HtoV_D7kg2Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+findings+from+the+Asian+Lymphoma+Study+Group%3A+focus+on+T+and+NK-cell+lymphomas&rft.jtitle=International+journal+of+hematology&rft.au=Chan%2C+Jason+Yongsheng&rft.au=Lim%2C+Soon+Thye&rft.date=2018-04-01&rft.issn=1865-3774&rft.eissn=1865-3774&rft.volume=107&rft.issue=4&rft.spage=413&rft_id=info:doi/10.1007%2Fs12185-018-2406-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0925-5710&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0925-5710&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0925-5710&client=summon